Site Articles

Background

Beginning in 1985, the United States government (USG) diplomatic and trade officials have engaged in wide ranging activities aimed at changing global norms for the protection of intellectual property rights, with a particular emphasis on the IPR protections for pharmaceutical products.

This note reports on U.S. Department of State cables sent in 1986 and 1987, that discussed the U.S. government efforts to change policies in Brazil on the intellectual property protection for pharmaceutical products. The cables have been obtained by KEI with a FOIA request.

Continue Reading →

The following statement was delivered by Thailand on Tuesday, 19 January 2010 during the discussion of agenda item 4.3 on public health, innovation and intellectual property. This statement requested Dr. Chan (Director-General, WHO) to conduct an investigation of the leaks of documents of the WHO Expert Working Group on R&D Financing to the IFPMA. In its statement, Thailand noted that the circle of trust had been broken.